Invest in the Future of AI-Driven Medicine.

Backed by Top VC's & Investors

Backed by World-Class Investors

Get Our Investor Deck & Exclusive Updates

Trusted by Scientists at

8,000

Clinical Samples

Analyzed

66

Hospital

Partnerships

12

Pending

Patents

Why Invest in Biostate?

The Future of Medicine

AI Revolutionizing Healthcare

Predicting disease evolution, and optimizing treatments.

A CEO with a Track Record

Over $110M raised on previous startups by our CEO

Successful Exits for Investors

Over $50M acquisition on previous startup by our CTO, giving a 4x return to investors

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

Backed by World-Class Institutions

Institutional-Grade Investment,

Now Open to the Public for a

limited time

Investors from Accel, Anthropic, 10X Genomics, Twist Biosciences... are already backing us.

Defensible Innovation

8,000+ Samples Analyzed

12 pending patents on cutting-edge AI-driven RNA sequencing technology.

Invest in the Future of

AI-Driven Medicine!

The Future of
Medicine

Proven Leadership,
Proven Success

A CEO with
a Track Record

Successful Exits
for Investor

Defensible
Innovation

Backed by
World-Class Investors

Biostate Team

Our leadership team brings together deep expertise in AI, genomics, and healthcare. Co-founders David Zhang and Ashwin Gopinath have established track records in biotech innovation and AI development, backed by leading investors from Anthropic, 10x Genomics, Twist Biosciences, etc.

David Zhang

Co-Founder/CEO

Co-Founder, NuProbe Global (2017-2023); CEO, NuProbe USA (2021-2023)

  • Raised over $110M of venture capital (inc. Sequoia China and AstraZeneca), achieved $21M revenue in 2022.

  • Led business partnerships with Bio-Rad, Adaptive Biotechnology, Gilead, Epizyme, Cepheid, and Oxford Nanopore.

  • Collaborated with clinicians from MD Anderson, Yale School of Medicine, Mayo Clinic, and BCM.

Associate Professor of Bioengineering, Rice University (2013-2021)

Ashwin Gopinath
Co-Founder/CTO

Assistant Professor of Mechanical Engineering, MIT (2020-2024)

Co-Founder and CTO, Palamedrix (2020-2022)

  • Raised $6M of venture funding, acquired by Somalogic for $50M+ in 2022.

Research Fellow, Google X (2017-2019)

  • Longitudinal medical imaging AI for detecting melanoma

Paul Rothemund

Ph.D. | VP of Research

  • Co-founder and CSO, Palamedrix

    (2020-2024)

  • Research Professor, Caltech (2008-2023)

  • MacArthur Fellow, 2007

Eva Miao
Head of Operations
  • CFO, Torus Biosystems (2022-2023)

  • VP Finance, Proven Skincare (2020-2022)

  • Head of FP&A, Genuity / Wuxi Apptec (2018-2020)

Alan Wright
M.D. | Cons. Head of Clin. Strategy.
  • Chief Medical Officer, Biomerieux

    (2021-2023)

  • Chief Medical Officer, Roche (2013-2020)

Timothy Kassis

Ph.D. | Head of AI

  • Head of AI and Data, Matterworks

    (2021-2025)

  • Instructor, MIT (2017-2021)

Wei Chen,
Ph.D. | Head of Bio Innovation
  • Sr. Scientist, Nuprobe (2020-2024)

  • Inventor on 12 patents

Nicolas Garreau
Ph.D. | Head of Bus. Dev.
  • Director of Bus. Dev, Nuprobe (2018-2023)

  • Bus. Dev. Fellow, Harvard Medical School (2015-2017)

27+ and growing...

Get Our Investor Deck & Exclusive Updates

Frequently Asked Questions

Why invest in startups?

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.

How much can I invest?

Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.

How do I calculate my net worth?

To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.

What are the tax implications of an equity crowdfunding investment?

We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.

Who can invest in a Regulation CF Offering?

Individuals over 18 years of age can invest.

Disclaimers

No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted, and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. "Reserving" securities is simply an indication of interest.